nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—AR—duct of salivary gland—head and neck cancer	0.151	0.641	CbGeAlD
Cyproterone acetate—Coma hepatic—Docetaxel—head and neck cancer	0.0288	0.0477	CcSEcCtD
Cyproterone acetate—Scleroderma—Docetaxel—head and neck cancer	0.0267	0.0442	CcSEcCtD
Cyproterone acetate—Azoospermia—Hydroxyurea—head and neck cancer	0.0258	0.0427	CcSEcCtD
Cyproterone acetate—Atrophy—Hydroxyurea—head and neck cancer	0.0213	0.0353	CcSEcCtD
Cyproterone acetate—Pulmonary fibrosis—Hydroxyurea—head and neck cancer	0.0158	0.0262	CcSEcCtD
Cyproterone acetate—Thromboembolic event—Docetaxel—head and neck cancer	0.0134	0.0222	CcSEcCtD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—CEBPA—head and neck cancer	0.0102	0.0641	CbGpPWpGaD
Cyproterone acetate—CYP19A1—FSH signaling pathway—AREG—head and neck cancer	0.00878	0.055	CbGpPWpGaD
Cyproterone acetate—Rash generalised—Docetaxel—head and neck cancer	0.0085	0.0141	CcSEcCtD
Cyproterone acetate—Pulmonary fibrosis—Docetaxel—head and neck cancer	0.00822	0.0136	CcSEcCtD
Cyproterone acetate—Tenderness—Hydroxyurea—head and neck cancer	0.00797	0.0132	CcSEcCtD
Cyproterone acetate—Ascites—Docetaxel—head and neck cancer	0.00795	0.0132	CcSEcCtD
Cyproterone acetate—Encephalopathy—Fluorouracil—head and neck cancer	0.0078	0.0129	CcSEcCtD
Cyproterone acetate—Creatinine increased—Hydroxyurea—head and neck cancer	0.00731	0.0121	CcSEcCtD
Cyproterone acetate—CYP19A1—connective tissue—head and neck cancer	0.00695	0.0295	CbGeAlD
Cyproterone acetate—Neoplasm—Vinblastine—head and neck cancer	0.0069	0.0114	CcSEcCtD
Cyproterone acetate—AR—Nuclear Receptors—RARB—head and neck cancer	0.00678	0.0424	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—CEBPA—head and neck cancer	0.00668	0.0418	CbGpPWpGaD
Cyproterone acetate—Menstruation irregular—Docetaxel—head and neck cancer	0.00653	0.0108	CcSEcCtD
Cyproterone acetate—Phlebitis—Vinblastine—head and neck cancer	0.00643	0.0106	CcSEcCtD
Cyproterone acetate—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.00632	0.0105	CcSEcCtD
Cyproterone acetate—Neoplasm—Hydroxyurea—head and neck cancer	0.00629	0.0104	CcSEcCtD
Cyproterone acetate—NR3C1—neck—head and neck cancer	0.00622	0.0264	CbGeAlD
Cyproterone acetate—AR—connective tissue—head and neck cancer	0.00615	0.0261	CbGeAlD
Cyproterone acetate—Polyp—Docetaxel—head and neck cancer	0.00594	0.00982	CcSEcCtD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—CEBPA—head and neck cancer	0.00588	0.0368	CbGpPWpGaD
Cyproterone acetate—AR—epithelium—head and neck cancer	0.00584	0.0248	CbGeAlD
Cyproterone acetate—Tenderness—Fluorouracil—head and neck cancer	0.00574	0.00949	CcSEcCtD
Cyproterone acetate—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00565	0.00934	CcSEcCtD
Cyproterone acetate—Embolism—Docetaxel—head and neck cancer	0.00563	0.00931	CcSEcCtD
Cyproterone acetate—Hepatic failure—Hydroxyurea—head and neck cancer	0.00562	0.00929	CcSEcCtD
Cyproterone acetate—Cyst—Docetaxel—head and neck cancer	0.00541	0.00894	CcSEcCtD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.00536	0.0335	CbGpPWpGaD
Cyproterone acetate—Leukocytosis—Fluorouracil—head and neck cancer	0.00533	0.00881	CcSEcCtD
Cyproterone acetate—NR3C1—Nuclear Receptors—RARB—head and neck cancer	0.00514	0.0322	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—CEBPA—head and neck cancer	0.00507	0.0317	CbGpPWpGaD
Cyproterone acetate—NR3C1—parotid gland—head and neck cancer	0.00506	0.0215	CbGeAlD
Cyproterone acetate—NR3C1—saliva-secreting gland—head and neck cancer	0.00485	0.0206	CbGeAlD
Cyproterone acetate—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00473	0.00782	CcSEcCtD
Cyproterone acetate—CYP19A1—thyroid gland—head and neck cancer	0.00462	0.0196	CbGeAlD
Cyproterone acetate—Coma—Fluorouracil—head and neck cancer	0.00458	0.00757	CcSEcCtD
Cyproterone acetate—Breast disorder—Hydroxyurea—head and neck cancer	0.00456	0.00755	CcSEcCtD
Cyproterone acetate—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00455	0.00753	CcSEcCtD
Cyproterone acetate—AR—lymphoid tissue—head and neck cancer	0.0045	0.0191	CbGeAlD
Cyproterone acetate—NR3C1—connective tissue—head and neck cancer	0.00446	0.0189	CbGeAlD
Cyproterone acetate—Pancreatitis—Hydroxyurea—head and neck cancer	0.00428	0.00708	CcSEcCtD
Cyproterone acetate—NR3C1—epithelium—head and neck cancer	0.00423	0.018	CbGeAlD
Cyproterone acetate—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00421	0.00696	CcSEcCtD
Cyproterone acetate—Thrombophlebitis—Fluorouracil—head and neck cancer	0.0042	0.00694	CcSEcCtD
Cyproterone acetate—Myocardial infarction—Vinblastine—head and neck cancer	0.00418	0.00692	CcSEcCtD
Cyproterone acetate—CYP19A1—head—head and neck cancer	0.00409	0.0174	CbGeAlD
Cyproterone acetate—AR—thyroid gland—head and neck cancer	0.00409	0.0173	CbGeAlD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.00406	0.0254	CbGpPWpGaD
Cyproterone acetate—Weight increased—Hydroxyurea—head and neck cancer	0.00397	0.00657	CcSEcCtD
Cyproterone acetate—Haemoglobin—Vinblastine—head and neck cancer	0.00385	0.00637	CcSEcCtD
Cyproterone acetate—Haemorrhage—Vinblastine—head and neck cancer	0.00383	0.00633	CcSEcCtD
Cyproterone acetate—NR3C1—trachea—head and neck cancer	0.00374	0.0159	CbGeAlD
Cyproterone acetate—Cardiac failure—Fluorouracil—head and neck cancer	0.00372	0.00616	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00368	0.00609	CcSEcCtD
Cyproterone acetate—AR—head—head and neck cancer	0.00363	0.0154	CbGeAlD
Cyproterone acetate—Pulmonary embolism—Docetaxel—head and neck cancer	0.00361	0.00598	CcSEcCtD
Cyproterone acetate—Injection site reaction—Docetaxel—head and neck cancer	0.00359	0.00594	CcSEcCtD
Cyproterone acetate—Haemoglobin—Hydroxyurea—head and neck cancer	0.00351	0.00581	CcSEcCtD
Cyproterone acetate—Haemorrhage—Hydroxyurea—head and neck cancer	0.00349	0.00578	CcSEcCtD
Cyproterone acetate—Fluid retention—Docetaxel—head and neck cancer	0.00343	0.00567	CcSEcCtD
Cyproterone acetate—Alopecia—Vinblastine—head and neck cancer	0.00338	0.0056	CcSEcCtD
Cyproterone acetate—Neoplasm—Docetaxel—head and neck cancer	0.00327	0.0054	CcSEcCtD
Cyproterone acetate—NR3C1—lymphoid tissue—head and neck cancer	0.00326	0.0138	CbGeAlD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—XRCC3—head and neck cancer	0.00324	0.0203	CbGpPWpGaD
Cyproterone acetate—Muscular weakness—Fluorouracil—head and neck cancer	0.00321	0.0053	CcSEcCtD
Cyproterone acetate—Angiopathy—Hydroxyurea—head and neck cancer	0.00317	0.00524	CcSEcCtD
Cyproterone acetate—Chills—Hydroxyurea—head and neck cancer	0.00313	0.00518	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Vinblastine—head and neck cancer	0.00309	0.00512	CcSEcCtD
Cyproterone acetate—Alopecia—Hydroxyurea—head and neck cancer	0.00309	0.0051	CcSEcCtD
Cyproterone acetate—Anaemia—Vinblastine—head and neck cancer	0.00308	0.0051	CcSEcCtD
Cyproterone acetate—Phlebitis—Docetaxel—head and neck cancer	0.00305	0.00504	CcSEcCtD
Cyproterone acetate—Thrombophlebitis—Docetaxel—head and neck cancer	0.00303	0.00501	CcSEcCtD
Cyproterone acetate—Malaise—Vinblastine—head and neck cancer	0.00301	0.00497	CcSEcCtD
Cyproterone acetate—Leukopenia—Vinblastine—head and neck cancer	0.00298	0.00494	CcSEcCtD
Cyproterone acetate—NR3C1—thyroid gland—head and neck cancer	0.00296	0.0126	CbGeAlD
Cyproterone acetate—Hepatic failure—Docetaxel—head and neck cancer	0.00292	0.00483	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00287	0.00474	CcSEcCtD
Cyproterone acetate—CYP19A1—lymph node—head and neck cancer	0.00287	0.0122	CbGeAlD
Cyproterone acetate—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00282	0.00467	CcSEcCtD
Cyproterone acetate—Anaemia—Hydroxyurea—head and neck cancer	0.00281	0.00465	CcSEcCtD
Cyproterone acetate—Discomfort—Vinblastine—head and neck cancer	0.0028	0.00464	CcSEcCtD
Cyproterone acetate—Hot flush—Docetaxel—head and neck cancer	0.0028	0.00464	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—XRCC3—head and neck cancer	0.00279	0.0175	CbGpPWpGaD
Cyproterone acetate—Menopausal symptoms—Docetaxel—head and neck cancer	0.00278	0.0046	CcSEcCtD
Cyproterone acetate—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00276	0.00457	CcSEcCtD
Cyproterone acetate—Myocardial infarction—Fluorouracil—head and neck cancer	0.00275	0.00454	CcSEcCtD
Cyproterone acetate—Malaise—Hydroxyurea—head and neck cancer	0.00274	0.00453	CcSEcCtD
Cyproterone acetate—Leukopenia—Hydroxyurea—head and neck cancer	0.00272	0.0045	CcSEcCtD
Cyproterone acetate—Cardiac failure—Docetaxel—head and neck cancer	0.00269	0.00445	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Vinblastine—head and neck cancer	0.00266	0.00441	CcSEcCtD
Cyproterone acetate—NR3C1—head—head and neck cancer	0.00263	0.0111	CbGeAlD
Cyproterone acetate—Anorexia—Vinblastine—head and neck cancer	0.00259	0.00429	CcSEcCtD
Cyproterone acetate—Migraine—Docetaxel—head and neck cancer	0.00258	0.00427	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00257	0.00425	CcSEcCtD
Cyproterone acetate—CYP19A1—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00256	0.016	CbGpPWpGaD
Cyproterone acetate—Discomfort—Hydroxyurea—head and neck cancer	0.00256	0.00423	CcSEcCtD
Cyproterone acetate—AR—lymph node—head and neck cancer	0.00254	0.0108	CbGeAlD
Cyproterone acetate—Haemoglobin—Fluorouracil—head and neck cancer	0.00253	0.00418	CcSEcCtD
Cyproterone acetate—Haemorrhage—Fluorouracil—head and neck cancer	0.00251	0.00416	CcSEcCtD
Cyproterone acetate—Oedema—Hydroxyurea—head and neck cancer	0.00248	0.0041	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—CEBPA—head and neck cancer	0.00247	0.0155	CbGpPWpGaD
Cyproterone acetate—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00243	0.00402	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00243	0.00402	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Docetaxel—head and neck cancer	0.00242	0.00401	CcSEcCtD
Cyproterone acetate—Skin disorder—Hydroxyurea—head and neck cancer	0.00241	0.00399	CcSEcCtD
Cyproterone acetate—Breast disorder—Docetaxel—head and neck cancer	0.00237	0.00392	CcSEcCtD
Cyproterone acetate—Anorexia—Hydroxyurea—head and neck cancer	0.00237	0.00391	CcSEcCtD
Cyproterone acetate—Decreased appetite—Vinblastine—head and neck cancer	0.00237	0.00391	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00236	0.00391	CcSEcCtD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—NOTCH1—head and neck cancer	0.00234	0.0147	CbGpPWpGaD
Cyproterone acetate—Constipation—Vinblastine—head and neck cancer	0.00233	0.00385	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00231	0.00383	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Vinblastine—head and neck cancer	0.00224	0.00371	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00223	0.00368	CcSEcCtD
Cyproterone acetate—Alopecia—Fluorouracil—head and neck cancer	0.00222	0.00367	CcSEcCtD
Cyproterone acetate—Dyspnoea—Hydroxyurea—head and neck cancer	0.00221	0.00366	CcSEcCtD
Cyproterone acetate—Dyspepsia—Hydroxyurea—head and neck cancer	0.00218	0.00361	CcSEcCtD
Cyproterone acetate—Decreased appetite—Hydroxyurea—head and neck cancer	0.00216	0.00357	CcSEcCtD
Cyproterone acetate—Abdominal pain—Vinblastine—head and neck cancer	0.00215	0.00356	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00214	0.00354	CcSEcCtD
Cyproterone acetate—Fatigue—Hydroxyurea—head and neck cancer	0.00214	0.00354	CcSEcCtD
Cyproterone acetate—Constipation—Hydroxyurea—head and neck cancer	0.00212	0.00351	CcSEcCtD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00207	0.013	CbGpPWpGaD
Cyproterone acetate—Weight increased—Docetaxel—head and neck cancer	0.00206	0.00341	CcSEcCtD
Cyproterone acetate—Weight decreased—Docetaxel—head and neck cancer	0.00205	0.00339	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00205	0.00338	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—RAD51—head and neck cancer	0.00204	0.0128	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00204	0.0128	CbGpPWpGaD
Cyproterone acetate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—head and neck cancer	0.00203	0.0127	CbGpPWpGaD
Cyproterone acetate—Anaemia—Fluorouracil—head and neck cancer	0.00202	0.00335	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Vinblastine—head and neck cancer	0.00201	0.00332	CcSEcCtD
Cyproterone acetate—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00199	0.0033	CcSEcCtD
Cyproterone acetate—Renal failure—Docetaxel—head and neck cancer	0.00199	0.00329	CcSEcCtD
Cyproterone acetate—Myocardial infarction—Docetaxel—head and neck cancer	0.00198	0.00328	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—STAT6—head and neck cancer	0.00198	0.0124	CbGpPWpGaD
Cyproterone acetate—Jaundice—Docetaxel—head and neck cancer	0.00197	0.00326	CcSEcCtD
Cyproterone acetate—Body temperature increased—Hydroxyurea—head and neck cancer	0.00196	0.00324	CcSEcCtD
Cyproterone acetate—Leukopenia—Fluorouracil—head and neck cancer	0.00196	0.00324	CcSEcCtD
Cyproterone acetate—Asthenia—Vinblastine—head and neck cancer	0.00195	0.00323	CcSEcCtD
Cyproterone acetate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—head and neck cancer	0.00193	0.0121	CbGpPWpGaD
Cyproterone acetate—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00191	0.00316	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—NAT2—head and neck cancer	0.00191	0.0119	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—NAT2—head and neck cancer	0.00188	0.0118	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.00186	0.0117	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Vinblastine—head and neck cancer	0.00186	0.00308	CcSEcCtD
Cyproterone acetate—Discomfort—Fluorouracil—head and neck cancer	0.00184	0.00304	CcSEcCtD
Cyproterone acetate—NR3C1—lymph node—head and neck cancer	0.00184	0.0078	CbGeAlD
Cyproterone acetate—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00183	0.00302	CcSEcCtD
Cyproterone acetate—Haemoglobin—Docetaxel—head and neck cancer	0.00182	0.00302	CcSEcCtD
Cyproterone acetate—Hepatitis—Docetaxel—head and neck cancer	0.00181	0.003	CcSEcCtD
Cyproterone acetate—Haemorrhage—Docetaxel—head and neck cancer	0.00181	0.003	CcSEcCtD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—MAPK3—head and neck cancer	0.00181	0.0113	CbGpPWpGaD
Cyproterone acetate—Dizziness—Vinblastine—head and neck cancer	0.0018	0.00298	CcSEcCtD
Cyproterone acetate—Oedema—Fluorouracil—head and neck cancer	0.00179	0.00295	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Docetaxel—head and neck cancer	0.00178	0.00295	CcSEcCtD
Cyproterone acetate—Asthenia—Hydroxyurea—head and neck cancer	0.00178	0.00294	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—RAD51—head and neck cancer	0.00176	0.011	CbGpPWpGaD
Cyproterone acetate—Nervous system disorder—Fluorouracil—head and neck cancer	0.00175	0.0029	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00175	0.00289	CcSEcCtD
Cyproterone acetate—Visual impairment—Docetaxel—head and neck cancer	0.00175	0.00289	CcSEcCtD
Cyproterone acetate—Tachycardia—Fluorouracil—head and neck cancer	0.00174	0.00288	CcSEcCtD
Cyproterone acetate—CYP19A1—FSH signaling pathway—MAPK3—head and neck cancer	0.00174	0.0109	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CASP8—head and neck cancer	0.00173	0.0109	CbGpPWpGaD
Cyproterone acetate—Vomiting—Vinblastine—head and neck cancer	0.00173	0.00286	CcSEcCtD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—MAPK1—head and neck cancer	0.00172	0.0108	CbGpPWpGaD
Cyproterone acetate—Erythema multiforme—Docetaxel—head and neck cancer	0.00172	0.00284	CcSEcCtD
Cyproterone acetate—Headache—Vinblastine—head and neck cancer	0.0017	0.00282	CcSEcCtD
Cyproterone acetate—Anorexia—Fluorouracil—head and neck cancer	0.0017	0.00282	CcSEcCtD
Cyproterone acetate—Diarrhoea—Hydroxyurea—head and neck cancer	0.0017	0.00281	CcSEcCtD
Cyproterone acetate—Eye disorder—Docetaxel—head and neck cancer	0.0017	0.0028	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.00169	0.0106	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00168	0.0105	CbGpPWpGaD
Cyproterone acetate—Hypotension—Fluorouracil—head and neck cancer	0.00167	0.00276	CcSEcCtD
Cyproterone acetate—CYP19A1—FSH signaling pathway—MAPK1—head and neck cancer	0.00165	0.0104	CbGpPWpGaD
Cyproterone acetate—Angiopathy—Docetaxel—head and neck cancer	0.00165	0.00272	CcSEcCtD
Cyproterone acetate—Dizziness—Hydroxyurea—head and neck cancer	0.00164	0.00271	CcSEcCtD
Cyproterone acetate—Immune system disorder—Docetaxel—head and neck cancer	0.00164	0.00271	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Docetaxel—head and neck cancer	0.00164	0.0027	CcSEcCtD
Cyproterone acetate—Chills—Docetaxel—head and neck cancer	0.00163	0.00269	CcSEcCtD
Cyproterone acetate—Nausea—Vinblastine—head and neck cancer	0.00162	0.00267	CcSEcCtD
Cyproterone acetate—Alopecia—Docetaxel—head and neck cancer	0.0016	0.00265	CcSEcCtD
Cyproterone acetate—Dyspnoea—Fluorouracil—head and neck cancer	0.00159	0.00263	CcSEcCtD
Cyproterone acetate—Mental disorder—Docetaxel—head and neck cancer	0.00159	0.00263	CcSEcCtD
Cyproterone acetate—Malnutrition—Docetaxel—head and neck cancer	0.00158	0.00261	CcSEcCtD
Cyproterone acetate—Vomiting—Hydroxyurea—head and neck cancer	0.00158	0.00261	CcSEcCtD
Cyproterone acetate—Dyspepsia—Fluorouracil—head and neck cancer	0.00157	0.0026	CcSEcCtD
Cyproterone acetate—Rash—Hydroxyurea—head and neck cancer	0.00156	0.00259	CcSEcCtD
Cyproterone acetate—Dermatitis—Hydroxyurea—head and neck cancer	0.00156	0.00259	CcSEcCtD
Cyproterone acetate—Headache—Hydroxyurea—head and neck cancer	0.00155	0.00257	CcSEcCtD
Cyproterone acetate—Decreased appetite—Fluorouracil—head and neck cancer	0.00155	0.00257	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00154	0.00255	CcSEcCtD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—PIK3CA—head and neck cancer	0.00149	0.00935	CbGpPWpGaD
Cyproterone acetate—Nausea—Hydroxyurea—head and neck cancer	0.00147	0.00244	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Fluorouracil—head and neck cancer	0.00147	0.00243	CcSEcCtD
Cyproterone acetate—Anaemia—Docetaxel—head and neck cancer	0.00146	0.00241	CcSEcCtD
Cyproterone acetate—Urticaria—Fluorouracil—head and neck cancer	0.00142	0.00235	CcSEcCtD
Cyproterone acetate—Syncope—Docetaxel—head and neck cancer	0.00142	0.00234	CcSEcCtD
Cyproterone acetate—Leukopenia—Docetaxel—head and neck cancer	0.00141	0.00234	CcSEcCtD
Cyproterone acetate—Body temperature increased—Fluorouracil—head and neck cancer	0.00141	0.00234	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Docetaxel—head and neck cancer	0.00139	0.0023	CcSEcCtD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—HRAS—head and neck cancer	0.00138	0.00865	CbGpPWpGaD
Cyproterone acetate—Cough—Docetaxel—head and neck cancer	0.00138	0.00228	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—head and neck cancer	0.00138	0.00863	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—STAT3—head and neck cancer	0.00136	0.0085	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00134	0.00221	CcSEcCtD
Cyproterone acetate—NR3C1—Endoderm Differentiation—NOTCH1—head and neck cancer	0.00132	0.00829	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Fluorouracil—head and neck cancer	0.00132	0.00218	CcSEcCtD
Cyproterone acetate—Oedema—Docetaxel—head and neck cancer	0.00129	0.00213	CcSEcCtD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CCND1—head and neck cancer	0.00128	0.00799	CbGpPWpGaD
Cyproterone acetate—Shock—Docetaxel—head and neck cancer	0.00127	0.0021	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Docetaxel—head and neck cancer	0.00126	0.00209	CcSEcCtD
Cyproterone acetate—Pruritus—Fluorouracil—head and neck cancer	0.00126	0.00209	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Docetaxel—head and neck cancer	0.00126	0.00209	CcSEcCtD
Cyproterone acetate—Tachycardia—Docetaxel—head and neck cancer	0.00126	0.00208	CcSEcCtD
Cyproterone acetate—Skin disorder—Docetaxel—head and neck cancer	0.00125	0.00207	CcSEcCtD
Cyproterone acetate—Anorexia—Docetaxel—head and neck cancer	0.00123	0.00203	CcSEcCtD
Cyproterone acetate—Diarrhoea—Fluorouracil—head and neck cancer	0.00122	0.00202	CcSEcCtD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—AKT1—head and neck cancer	0.00122	0.00764	CbGpPWpGaD
Cyproterone acetate—Hypotension—Docetaxel—head and neck cancer	0.0012	0.00199	CcSEcCtD
Cyproterone acetate—Dizziness—Fluorouracil—head and neck cancer	0.00118	0.00195	CcSEcCtD
Cyproterone acetate—CYP19A1—FSH signaling pathway—AKT1—head and neck cancer	0.00117	0.00734	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Docetaxel—head and neck cancer	0.00115	0.0019	CcSEcCtD
Cyproterone acetate—Vomiting—Fluorouracil—head and neck cancer	0.00114	0.00188	CcSEcCtD
Cyproterone acetate—Dyspepsia—Docetaxel—head and neck cancer	0.00113	0.00188	CcSEcCtD
Cyproterone acetate—Rash—Fluorouracil—head and neck cancer	0.00113	0.00186	CcSEcCtD
Cyproterone acetate—Dermatitis—Fluorouracil—head and neck cancer	0.00113	0.00186	CcSEcCtD
Cyproterone acetate—Decreased appetite—Docetaxel—head and neck cancer	0.00112	0.00185	CcSEcCtD
Cyproterone acetate—Headache—Fluorouracil—head and neck cancer	0.00112	0.00185	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00111	0.00184	CcSEcCtD
Cyproterone acetate—Fatigue—Docetaxel—head and neck cancer	0.00111	0.00184	CcSEcCtD
Cyproterone acetate—Constipation—Docetaxel—head and neck cancer	0.0011	0.00182	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Docetaxel—head and neck cancer	0.00106	0.00176	CcSEcCtD
Cyproterone acetate—Nausea—Fluorouracil—head and neck cancer	0.00106	0.00175	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00105	0.00174	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—head and neck cancer	0.00103	0.00643	CbGpPWpGaD
Cyproterone acetate—Body temperature increased—Docetaxel—head and neck cancer	0.00102	0.00169	CcSEcCtD
Cyproterone acetate—Abdominal pain—Docetaxel—head and neck cancer	0.00102	0.00169	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.00102	0.00637	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Docetaxel—head and neck cancer	0.00095	0.00157	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CCND1—head and neck cancer	0.000944	0.00591	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—GSTM1—head and neck cancer	0.000941	0.00589	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000928	0.00581	CbGpPWpGaD
Cyproterone acetate—Asthenia—Docetaxel—head and neck cancer	0.000925	0.00153	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—RARB—head and neck cancer	0.000925	0.00579	CbGpPWpGaD
Cyproterone acetate—Pruritus—Docetaxel—head and neck cancer	0.000912	0.00151	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—PTEN—head and neck cancer	0.000911	0.0057	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP1A1—head and neck cancer	0.000892	0.00559	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL2—head and neck cancer	0.00089	0.00557	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Docetaxel—head and neck cancer	0.000882	0.00146	CcSEcCtD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00088	0.00551	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CCND1—head and neck cancer	0.000867	0.00543	CbGpPWpGaD
Cyproterone acetate—Dizziness—Docetaxel—head and neck cancer	0.000853	0.00141	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—YAP1—head and neck cancer	0.000842	0.00527	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.000839	0.00526	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—PTEN—head and neck cancer	0.000837	0.00524	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.000829	0.00519	CbGpPWpGaD
Cyproterone acetate—Vomiting—Docetaxel—head and neck cancer	0.00082	0.00136	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—STAT3—head and neck cancer	0.000814	0.0051	CbGpPWpGaD
Cyproterone acetate—Rash—Docetaxel—head and neck cancer	0.000813	0.00134	CcSEcCtD
Cyproterone acetate—Dermatitis—Docetaxel—head and neck cancer	0.000812	0.00134	CcSEcCtD
Cyproterone acetate—Headache—Docetaxel—head and neck cancer	0.000808	0.00134	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—UROD—head and neck cancer	0.000785	0.00491	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL2—head and neck cancer	0.000784	0.00491	CbGpPWpGaD
Cyproterone acetate—Nausea—Docetaxel—head and neck cancer	0.000766	0.00127	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—EGFR—head and neck cancer	0.00074	0.00464	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.000722	0.00452	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.00072	0.00451	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.000714	0.00447	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—AKT1—head and neck cancer	0.00071	0.00445	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—RARB—head and neck cancer	0.000702	0.00439	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.0007	0.00438	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000695	0.00435	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—YAP1—head and neck cancer	0.000638	0.004	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—head and neck cancer	0.00063	0.00395	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.00062	0.00388	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000618	0.00387	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000609	0.00381	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—head and neck cancer	0.0006	0.00376	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000597	0.00374	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000597	0.00374	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TP53—head and neck cancer	0.000571	0.00358	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000567	0.00355	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000566	0.00354	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000539	0.00337	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000532	0.00333	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000525	0.00329	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—AKT1—head and neck cancer	0.000525	0.00329	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000513	0.00321	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000512	0.00321	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—head and neck cancer	0.000503	0.00315	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000494	0.0031	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000485	0.00304	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000485	0.00304	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000464	0.0029	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—STAT3—head and neck cancer	0.000456	0.00286	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000447	0.0028	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—RARB—head and neck cancer	0.000445	0.00279	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000429	0.00269	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—head and neck cancer	0.000425	0.00266	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000422	0.00265	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000417	0.00261	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000417	0.00261	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000407	0.00255	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—YAP1—head and neck cancer	0.000405	0.00254	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000402	0.00252	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000402	0.00252	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000398	0.00249	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000379	0.00237	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.00035	0.00219	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000349	0.00218	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000346	0.00217	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000344	0.00215	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000343	0.00214	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—RARB—head and neck cancer	0.000338	0.00212	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000337	0.00211	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NAT2—head and neck cancer	0.000326	0.00204	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—YAP1—head and neck cancer	0.000307	0.00192	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000296	0.00185	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000288	0.0018	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—DPYD—head and neck cancer	0.000286	0.00179	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000285	0.00178	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—YAP1—head and neck cancer	0.000271	0.0017	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000204	0.00128	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NOTCH1—head and neck cancer	0.000183	0.00114	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000178	0.00111	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TYMS—head and neck cancer	0.000163	0.00102	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTM1—head and neck cancer	0.000161	0.00101	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GPX1—head and neck cancer	0.000154	0.000965	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP1A1—head and neck cancer	0.000153	0.000955	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NOTCH1—head and neck cancer	0.000139	0.000867	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000125	0.000785	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MAPK3—head and neck cancer	0.000101	0.000633	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS2—head and neck cancer	9.07e-05	0.000568	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTEN—head and neck cancer	7.91e-05	0.000495	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MAPK3—head and neck cancer	7.66e-05	0.00048	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—AKT1—head and neck cancer	6.81e-05	0.000427	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CA—head and neck cancer	5.58e-05	0.000349	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AKT1—head and neck cancer	5.17e-05	0.000324	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKT1—head and neck cancer	4.56e-05	0.000285	CbGpPWpGaD
